METHODS OF USING PEMBROLIZUMAB AND TREBANANIB Application WO-2019028012-A3 World Intellectual Property Organisation (WIPO) 28 Feb 2019
IMMUNOPOTENTIATOR CONTAINING ANTI-ANG2 ANTIBODY Application EP-3184543-A3 European Patent Office 23 Aug 2017